Warner Bros reopens Paramount talks, Tripadvisor to revamp board
AI Sentiment
Highly Positive
8/10
as of 02-17-2026 3:59pm EST
Masimo Corp is a technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
| Founded: | 1989 | Country: | United States |
| Employees: | N/A | City: | IRVINE |
| Market Cap: | 7.0B | IPO Year: | 2007 |
| Target Price: | $188.80 | AVG Volume (30 days): | 726.7K |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -10.55 | EPS Growth: | N/A |
| 52 Week Low/High: | $125.94 - $194.88 | Next Earning Date: | 02-26-2026 |
| Revenue: | $2,182,000,000 | Revenue Growth: | 38.48% |
| Revenue Growth (this year): | -25.9% | Revenue Growth (next year): | 6.83% |
| P/E Ratio: | N/A | Index: | N/A |
| Free Cash Flow: | 190.4M | FCF Growth: | -3.45% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
MASI Breaking Stock News: Dive into MASI Ticker-Specific Updates for Smart Investing
AI Sentiment
Highly Positive
8/10
See how MASI stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "MASI Masimo Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.